D-0207-2017 Class III Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-0207-2017 was initiated by Zydus Pharmaceuticals USA Inc on Nov 2, 2016 and is designated Class III. Reason for recall: Failed Dissolution Specifications; 6 month time point The recall status is terminated (terminated Jul 23, 2020). Affected quantity: 16,356 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 28, 2016
Initiation Date
Nov 2, 2016
Termination Date
Jul 23, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,356 bottles

Product description

BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, Rx Only, a) 30 count bottles (NDC 68382-354-06) and b) 500 count bottles (NDC 68382-354-05), Manufactured by: Cadila Healthcare LTD. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534

Reason for recall

Failed Dissolution Specifications; 6 month time point

Distribution pattern

Nationwide

Code information

a) MS1667 exp 01/2018; M601708, exp 03/2018; b) MS1667, MS1668, MS1669, exp 01/2018; M601515, M601516, exp 03/2018; M602920, M602921, M605399, M602937, M602938, M602939, exp 04/2018; M603988, exp 06/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0207-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0207-2017. Report a data issue: hello@regdatalab.com.